Drug Approval During a Public Health Crisis
FDA’s approval of an Ebola vaccine can serve as a framework for drug development during other epidemics.
Rethinking the Value of a Statistical Life
It is time to reconsider the value of the VSL in policy analysis.
Evaluating Soda Taxes
As cities experiment with soda taxes, emerging scholarship reviews their impacts and efficacy.
The Origins of GAO’s Ukraine Funding Report
Government Accountability Office report on military aid reflects historical tug-of-war between Congress and the President.
Proposed Rule Seeks to Promote Value-Based Health Care
Federal regulators seek to expand safe harbors for provider care coordination arrangements.
A Proposed Rule to Secure the Digital Economy
A Department of Commerce proposal would establish broad authority to block threats to digital security.
Proposed EPA Rule May Permit More Toxic Water Pollution
EPA’s proposed relaxation of a rule restricting water pollution from coal plants generates controversy.
Will the White House’s AI Policies Lead to Permissionless Innovation?
New artificial intelligence guidelines aim to improve oversight of growing automation in the United States.
The Jury Is Still Out on One-In-One-Out
The European Commission’s commitment to a new regulatory scheme risks misallocating resources and ossifying policy making.
Regulating Mobile Medical Applications
As mobile medical applications continue to proliferate, regulators lack a solid framework for oversight.
Federal Agencies’ Westward Expansion
The Bureau of Land Management’s relocation sets the stage for other federal agencies to leave Washington.
The Little Health Bill That Could
A proposed law would reduce the amount households spend on health care each year.